Evan Facher is Vice Chancellor for Innovation and Entrepreneurship, Associate Dean for Commercial Translation in the University of Pittsburgh School of Medicine and Director of the Innovation Institute at the University of Pittsburgh. In this role, Evan promotes the commercial and societal potential of faculty and student discoveries, and works with regional businesses to enhance the Pittsburgh regional innovation ecosystem. Most recently, Evan was President/CEO of SironRX Therapeutics, a private, clinical-stage company developing novel drug therapies. Prior to this, Evan worked in Bayer Healthcare’s medical device division as General Manager of its Pittsburgh Interventional business. During this tenure Evan also served as Executive Director of Corporate Development overseeing company strategy and M&A. Evan started his career as Senior Manager Business Development at the biotechnology company Athersys, where he was a business development leader creating partnerships with global pharmaceutical companies. Over his career, Evan has been involved with corporate fundraisings bringing in nearly $100 million from venture, strategic partner and grant sources as well as a leader in company and product acquisitions totaling over $600 million of investments. Evan holds a Ph.D. in Human Genetics from the University of Pittsburgh an MBA with a concentration in Entrepreneurship from Case Western Reserve University and a B.S. in Biology from the University of Miami (FL).